Michael L. Chang
CIK 1919832 · Chief Medical Officer · last filed 2026-03-11
Michael L. Chang is a Chief Medical Officer who has filed 4 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for NUTX, was dated Mar 11, 2026. Current disclosed insider exposure totals $16.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$16.27M
1
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NUTX | Chief Medical Officer | 82,356 | $197.51 | $16.27M | $0 | 4 | 2026-03-11 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-11 | NUTX | Mixed | +1,315 | -$66.3K | EDGAR |
| 2025-04-14 | NUTX | Mixed | +984 | -$19.2K | EDGAR |
| 2024-06-28 | NUTX | Grant (A) | — | $0 | EDGAR |
| 2022-04-05 | NUTX | Grant (A) | +12,008,523 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.